YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
102 hedge funds and large institutions have $128M invested in Y-mAbs Therapeutics in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
43% less capital invested
Capital invested by funds: $225M → $128M (-$97.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
102
Holding in Top 10
1
Calls
$171K
Puts
$9K
Top Buyers
| 1 | +$2.55M | |
| 2 | +$1.91M | |
| 3 | +$1.65M | |
| 4 |
Morgan Stanley
New York
|
+$795K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$687K |
Top Sellers
| 1 | -$7.83M | |
| 2 | -$3.33M | |
| 3 | -$2.33M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$1.39M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$527K |
